openPR Logo
Press release

Bleeding Disorders Market Key Players : Novo Nordisk, Bayer AG, Baxter International Inc., Alnylam Pharmaceuticals, Inc., Pfizer, Inc., Xenetic Biosciences, Inc.

11-05-2018 09:44 AM CET | Health & Medicine

Press release from: Allied Market Research

Bleeding Disorders Market

Bleeding Disorders Market

The bleeding disorder is a condition in which there is a problem associated with the normal blood clotting process in the body, which gets affected. Hence, therapies to stop bleeding are on high demand.

The key players in the global bleeding disorder treatment are Novo Nordisk, Bayer AG, Baxter International Inc., Alnylam Pharmaceuticals, Inc., Pfizer, Inc., Xenetic Biosciences, Inc., Bristol-Myers Squibb Company, Sanofi, Amgen, Inc., Janssen Global Services, LLC, and Bioverativ, Inc.
Get Sample PDF Brochure : https://www.alliedmarketresearch.com/request-toc-and-sample/2801

Rise in R&D investments, increase in the preference for prophylactic treatment, development of novel products, and increase in the prevalence of hemophilia are expected to expedite the growth of the bleeding disorders market globally. However, insufficient reimbursements and high costs of hemophilic drugs may restrain the market growth. Factors such as improvement of healthcare facilities in developing nations and introduction of biosimilar products will provide growth opportunities for the market.

The report segments the bleeding disorders market on the basis of type, drug class, and region. On the basis of types, it is segmented into hemophilia A, hemophilia B, von Willebrand disease, and others. On the basis of drug class, it is segmented into plasma-derived coagulation factor concentrates (factor VIII, factor IX, factor for von Willebrand disease, and activated prothrombin complex concentrates), recombinant coagulation factor concentrates (factor VIII, factor for von Willebrand disease, and factor IX), desmopressin, antifibrinolytics, fibrin sealants, and others.

Geographically the market has been analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Key Benefits

• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate imminent investment pockets.
• Comprehensive analysis of all geographical regions has been provided, which helps determine prevailing opportunities.
• Key players have been profiled and their strategies thoroughly analysed, which helps understand the competitive outlook of the global market.
• The report offers a quantitative analysis from 2016 to 2023, which is expected to enable stakeholders to capitalize on prevailing market opportunities.
• Exhaustive analysis of the global bleeding disorder market by type helps understand the types of drugs that are currently being used along with the variants that would gain prominence in future.

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bleeding Disorders Market Key Players : Novo Nordisk, Bayer AG, Baxter International Inc., Alnylam Pharmaceuticals, Inc., Pfizer, Inc., Xenetic Biosciences, Inc. here

News-ID: 1351333 • Views:

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collect
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in

All 5 Releases


More Releases for Bleeding

Growth Of Bleeding Disorder Testing Market Driven By Increasing Clinical Trials: …
The Bleeding Disorder Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Bleeding Disorder Testing Market? The bleeding disorder testing market size has increased strongly in recent years. It will rise from $14.99 billion in 2024 to $16.23 billion
Rise In The Incidences Of Upper Gastrointestinal Bleeding: Key Factor Driving Th …
The Gastrointestinal Bleeding Treatment Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Gastrointestinal Bleeding Treatment Devices Market Size During the Forecast Period? Recent years have seen a robust growth in the market size of devices used in the treatment of gastrointestinal
Key Trend Reshaping the Bleeding Disorder Testing Market in 2025: Innovative Gen …
What industry-specific factors are fueling the growth of the bleeding disorder testing market? The bleeding disorder testing market is poised for growth, buoyed by the rise in clinical trials. Clinical trials, which test the safety and efficiency of new medical care methods, therapies, drugs, or technology in humans, are increasing due to advancements in medical research, more healthcare innovation investment, and an upsurge in demand for novel treatments and therapies. Bleeding
Transforming the Bleeding Disorder Testing Market in 2025: Growth Of Bleeding Di …
What Is the Expected Size and Growth Rate of the Bleeding Disorder Testing Market? The market size for bleeding disorder testing has witnessed robust growth in recent years. The market value is projected to increase from $14.99 billion in 2024 to a whopping $16.23 billion in 2025, registering a compound annual growth rate (CAGR) of 8.3%. The rate of growth recorded in the historic period is associated with factors such as
Bleeding Disorders Market Is Driven By Bleeding Disorders In Various Industries, …
The Bleeding Disorders Market is a critical component of the healthcare industry, focused on the diagnosis, treatment, and management of bleeding disorders that affect individuals' blood clotting mechanisms. These disorders, which include hemophilia, von Willebrand disease, and various clotting factor deficiencies, can lead to prolonged and spontaneous bleeding, posing significant health risks. This market encompasses a range of therapies, medications, and diagnostic tools designed to address the unique needs of
Global Cyclic Heavy Menstrual Bleeding Market
Global Cyclic Heavy Menstrual Bleeding Market Heavy menstrual bleeding (HMB) is one of the most common debilitating gynecologic disorders that is affecting women of reproductive age. Increasing incidence rate drives the growth of the cyclic heavy menstrual bleeding market. Rising cases of uterine fibroids and polyps boost the growth of cyclic heavy menstrual bleeding. In addition, effective treatment cost and easy availability of treatment options plays a significant role in